Green tea compound may slow prostate cancer
New findings suggest that an antioxidant found in green tea may play a role in preventing the development of prostate cancer, which is the second most common type of cancer among men. The study, published in Cancer Prevention Research, analyzed the link between epigallocatechin-3-gallate (EGCG) and the suppression of prostate cancer development among 97 men with premalignant lesions. Although the overall cancer rate was not lower among those who were administered 400 milligrams of EGCG on a daily basis (equivalent to about 5 cups of green tea), the test subjects displayed lower rates of premalignant lesions and biomarkers associated with a higher risk of prostate cancer. 220,000 cases of prostate cancer are estimated to be diagnosed in the US in 2015.